Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > nCoat files Chapter 11 bankruptcy

August 27th, 2010

nCoat files Chapter 11 bankruptcy

Abstract:
NCoat, a nanotechnology firm that has been one of the Triad's biggest commercial employers in that emerging industry, has filed for Chapter 11 bankruptcy.

Company officials say reorganizing under protection of the bankruptcy court will clear the way for a rebound under new ownership. A California private equity firm, Fort Ashford Funds, has agreed to take over the company and continue its operation, but isn't willing to take on a pile of debt, according to CEO Paul Clayson.

Source:
bizjournals.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026

COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026

Breathing new life into nanotubes for a cooler planet:Researchers at Skoltech discover a simple, single-step heat treatment that nearly doubles the CO2-trapping power of carbon nanotubes January 30th, 2026

New light-based nanotechnology could enable more precise, less harmful cancer treatment: The approach offers a potential alternative to chemotherapy and radiation by using light and heat to target cancer cells. January 30th, 2026

Announcements

Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026

COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026

Breathing new life into nanotubes for a cooler planet:Researchers at Skoltech discover a simple, single-step heat treatment that nearly doubles the CO2-trapping power of carbon nanotubes January 30th, 2026

New light-based nanotechnology could enable more precise, less harmful cancer treatment: The approach offers a potential alternative to chemotherapy and radiation by using light and heat to target cancer cells. January 30th, 2026

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project